We are live on ! Find out more
FEED

ENVUE MEDICAL INC NEW
FEED

Delisted

FEED was delisted on the 15th of September, 2026.

3 hedge funds and large institutions have $67.5K invested in ENVUE MEDICAL INC NEW in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

10.46% less ownership

Funds ownership: 13.07%2.61% (-10%)

63% less funds holding

Funds holding: 83 (-5)

69% less capital invested

Capital invested by funds: $215K → $67.5K (-$148K)

83% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 6

Holders
3
Holders Change
-5
Holders Change %
-62.5%
% of All Funds
0.04%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
2
Reduced
Closed
6
Calls
Puts
Net Calls
Net Calls Change

FEED Hedge Fund Activity: Q1 2025 in Review

3 of the 7,473 institutional investors tracked by Wall St. Rank reported a position in ENVUE MEDICAL INC NEW (FEED) for Q1 2025, worth a combined $67.5K — down 69% from $215K a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of FEED and 1 opened new positions — a net loss of 5 holders — while 0 trimmed existing stakes and 2 added.

The largest buyer was Morgan Stanley, opening a new position worth an estimated $62.2K. The largest seller was Armistice Capital, exiting entirely with an estimated $112K sold.

  • 3 institutional investors held ENVUE MEDICAL INC NEW (FEED) as of Q1 2025, down from 8 in Q4 2024.
  • Funds reported $67.5K of ENVUE MEDICAL INC NEW stock for Q1 2025, down 69% quarter-over-quarter.
  • 1 fund opened new ENVUE MEDICAL INC NEW positions in Q1 2025 and 6 closed out, a net change of -5 holders.
  • The largest ENVUE MEDICAL INC NEW buyer in Q1 2025 was Morgan Stanley, an estimated $62.2K added.
  • The largest ENVUE MEDICAL INC NEW seller in Q1 2025 was Armistice Capital, an estimated $112K sold.

Based on aggregated 13F filings for Q1 2025.